Feist E, Egerer K, Burmester G-R
Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin.
Z Rheumatol. 2007 May;66(3):212-4, 216-8. doi: 10.1007/s00393-007-0159-3.
Antibodies against citrullinated protein/peptides antigens (ACPA) are well recognized serological markers for rheumatoid arthritis. In addition to rheumatoid factor, they provide high diagnostic specificity and are also useful diagnostic tools in the search for early disease manifestation. As shown by several studies, both autoantibodies correlate with disease severity and the radiologic progression of rheumatoid arthritis. However, it is important to note that only the detection of rheumatoid factors is internationally standardized. Whether autoantibody profiling is also of significance for the stratification and monitoring of rheumatoid arthritis is the focus of ongoing investigations.
抗瓜氨酸化蛋白/肽抗原(ACPA)抗体是类风湿性关节炎公认的血清学标志物。除类风湿因子外,它们具有很高的诊断特异性,也是用于寻找疾病早期表现的有用诊断工具。多项研究表明,这两种自身抗体均与类风湿性关节炎的疾病严重程度和放射学进展相关。然而,需要注意的是,只有类风湿因子的检测实现了国际标准化。自身抗体谱分析对类风湿性关节炎的分层和监测是否也具有重要意义,是正在进行的研究重点。